Viewing Study NCT03516760


Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2025-12-26 @ 3:33 AM
Study NCT ID: NCT03516760
Status: TERMINATED
Last Update Posted: 2022-09-29
First Post: 2018-04-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose-escalating Phase I Trial With GEM333 in Patients With Acute Myeloid Leukemia
Sponsor: AvenCell Europe GmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module